Positive earnings reviews appear to have get over that irrational pessimism spawned by Bernacke’s gloomy comments. All day long NYAD readings were WAY up and were suffered. Volume was unconvincing but HEY! Thursday night Don Worden said Tuesday WAS a key reversal day and we’re now poised for a fresh uptrend. OK Don. For my very own part I closed my brief FXE position at the open up and were able to book a whooping .05 gain. Live and learn. I will have played my usual daytrader role and pocketed revenue at Wednesday’s close. For now I’ll just reload and wait for the next set up. BZF is on a higher volume tear and check out the MoneyStream value .
As an apart, I live in an over 55 community where I’m the existing HOA President, serve on a number of advisory committees and preside over a little investment club. A lot of my fellow residents are now VERY conservative using their investments, having suffered major hits to their IRAs and other investments in 2008-09 and are limping along on .5 % CD earnings. So, for the truly risk adverse here’s a doctoral paper on a fascinating collar strategy focused on the Qs that has regularly yielded almost 10% yearly with very managed risk. Now, 10% doesn’t seem like a lot but it is 20 times better than .5% and the machine requires hardly any maintenance. Worth a look IMHO. Also consider the potential results using QLD, SSO or other combined higher beta ETFs with (and this is key) very strong options open interest chains and .01 option bet/ask spreads.
These goals have included, amongst others, the acquisition of medical technology companies with strong growth potential identified in the general public market easily. We believe that the back-ground of our management and of our Board of Directors in the technology markets is a very important resource which makes us an appealing business partner. We be prepared to work to suppose a dynamic role in the development and growth of the new company, providing both strategic guidance and functional support. The management of iGambit feels that it can leverage its collective experience to help position the combined company to create high-margin, predictable and repeating profits and create long-term value for our stockholders.
Information on our web-site will not comprise an integral part of this news release. SMITHTIOWN, NY-(Marketwire-August 17, 2017) – iGambit Inc. (OTCBB: IGMB) is pleased to announce that the company’s wholly possessed subsidiary, HealthDatix, Inc. has joined into a pilot program with West Florida Health Network (WFHN), which really is a Community Integrated Network (CIN). The West Florida Health Network has been selected by two large Tampa Bay healthcare systems to be their supplier of choice for their employee health benefit plans.
HealthDatix will provide the web Health Risk Assessment (HRA) tool to assist in the execution of the HRA and provide WFHN the info analytics on their employee population. Additionally, HealthDatix will provide an individual Preventive Plan (PPP) to the worker and their dependents to assist in maintaining a wholesome life-style.
The two health systems have around 22,000 protected lives. The response from the ongoing health Care Providers has been very positive. Our focus is on creating a strong distribution platform by dealing with both Vendor Partners and Channel Partners to facilitate the implementation of both the Annual Wellness Visit (AWV) program, and medical Risk Assessment (HRA) program. The HealthDatix sales force has centered on the private commercial market, increasing its platform to facilitate providing personal- insured marketplaces with something to capture the data to augment their organizations wellbeing programs.
- Succession advice
- The recommended term-to-maturity for fixed-income instruments
- N.Y.C. Events Guide
- “Growth at a reasonable price” investing
About iGambit Inc: iGambit (OTCBB: IGMB) is a completely reporting publicly-held company. We are a ongoing company focused on pursuing specific medical strategies and goals. These objectives have included, amongst others, the acquisition of medical technology companies with strong growth potential easily recognized in the public arena. We think that the back-ground of our management and of our Board of Directors in the technology markets is a valuable resource that makes us an appealing business partner.
We expect to work to assume a dynamic role in the development and development of the new company, providing both tactical guidance and operational support. The management of iGambit feels that it can leverage its collective expertise to help position the mixed company to produce high-margin, recurring and predictable profits and create long-term value for our stockholders. In the past several months some significant events have occurred at iGambit.
On February 14, 2017 we obtained HubCentrix, Inc. (HubCentrix) and on April 6, 2017 we acquired the resources of the CyberCare Health Network Division from EncounterCare Solutions Inc. (ECSL). Both are in the health wellbeing business. Their services are complementary and are operating under our owned subsidiary HealthDatix wholly, Inc. (HealthDatix). 6 million in liabilities from our balance sheet.
As due to the ECSL purchase we have gained the ECSL shareholders as new appreciated shareholders of iGambit. We welcome you as you sign up for our existing devoted iGambit shareholders and look forward to a booming future together. Previously we were an organization centered on the technology markets. With the two recent acquisitions and the ArcMail sale, we now tailor our focus entirely on the medical technology markets.